Nipro recalls bicarbonate dialysate concentrate due to contamination. Learn about potential serious injuries, fatality risks and essential steps for healthcare providers and patients for this Class I recall.
Similar Posts
Scientific Protein Laboratories, LLC – 712578 – 10/10/2025
CGMP/Active Pharmaceutical Ingredient (API)/AdulteratedGeneric Drugs Forum (GDF) 2026 – 04/22/2026
FDA’s annual Generic Drugs Forum is a two-day event designed to facilitate the development and approval of safe, effective, and high-quality generic medicines. Join us April 22-23, 2026.Molecular PharmaGroup LLC. New Providence, NJ. 483 issued 08/11/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 08/11/2025
Short Title (70 char) Molecular PharmaGroup LLC. New Providence, NJ. 483 issued 08/11/2025
FEI Number 3014413265
Firm Name Molecular PharmaGroup LLC
Record Type 483
State NJ
Establishment Type OutsourPrimary Care Providers Can Prescribe with Confidence
Information and resources are available to help primary care providers manage OUD with the help of medications for opioid use disorder (MOUD).Early Lyme Disease as Manifested by Erythema Migrans: Developing Drugs for Treatment
Early Lyme Disease as Manifested by Erythema Migrans: Developing Drugs for TreatmentSumitomo Pharma Co., Ltd. 8/7/2025 483
Record Date: 08/7/2025
Entity Name: Sumitomo Pharma Co., Ltd.
FEI Number: 3003028650
Record Type: 483
Country: Japan
Establishment Type: Drug Manufacturer